David Emerson Jorden, CEO/CFO at Nuo Therapeutics, Inc. (AURX), sold 200,000 shares at $1.50 ($300K) on 2025-11-28, disclosed to the SEC on 2025-12-03.
Open-market sale of $300k AURX by CEO/CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |
| CMXI | BUY | 2013-05-21 | $40K | — | Filing → |